...
首页> 外文期刊>Sexually transmitted diseases >Use of DNA purification kits for polymerase chain reaction testing of Gen-Probe Chlamydia trachomatis PACE 2 specimens.
【24h】

Use of DNA purification kits for polymerase chain reaction testing of Gen-Probe Chlamydia trachomatis PACE 2 specimens.

机译:DNA纯化试剂盒用于Gen-Probe沙眼衣原体PACE 2标本的聚合酶链反应测试。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND OBJECTIVES: Confirmation testing using nucleic acid amplification has been shown to improve the sensitivity and specificity of screening tests for Chlamydia trachomatis. However, no critical information on the use of these techniques as an adjunct to Gen-Probe hybridization testing, one of the most common screening methods, has been reported to date. We examined the Roche AMPLICOR PCR C. trachomatis Test (Roche Diagnostic Systems, Branchburg, NJ) as a confirmatory test for the Gen-Probe PACE 2 C. trachomatis Test (San Diego, CA). Further, to mitigate the possible effect of interfering compounds in the Gen-Probe PACE 2 transport medium, we tested various DNA purification techniques. STUDY DESIGN: C. trachomatis elementary bodies were used to spike PACE 2 Transport medium, which was serially diluted, then tested by polymerase chain reaction (PCR). Six parallel dilution series were conducted: (1) saline dilutions tested by the Syva Direct Specimen Test, (2) Roche AMPLICOR transport medium dilutions tested by PCR, and (3-6) dilutions in PACE 2 transport medium purified respectively by GENECLEAN II (BIO101, Vista, CA), Puregene (Gentra Systems, Inc., Research Triangle Park, NC), Microcon 100 (Amicon, Inc., Beverly, MA) DNA isolation kits, and no DNA purification, all tested by PCR. The system giving the best results by in vitro endpoint dilution trials was then used to confirm human specimens previously tested by the Gen-Probe method. RESULTS: PCR detected C. trachomatis at 11 twofold dilutions greater than PACE 2 and equivalent to detection of single elementary body by Syva Direct Specimen Test. DNA purification of spiked PACE 2 transport medium by the Microcon 100 kit produced the most consistent PCR detection endpoints, equivalent to endpoints of spiked AMPLICOR transport medium. Endpoints with no DNA purification step were variable and lower. Of 78 endocervical specimens negative by PACE 2 and Gen-Probe Probe Competition Assay, 12 (15.3%) were positive by Microcon DNA purification/PCR testing. CONCLUSIONS: PCR can be used as confirmation method for Gen-Probe PACE 2 testing, but testing must be performed with a DNA purification procedure.
机译:背景与目的:已经证明使用核酸扩增的确认测试可提高沙眼衣原体筛查测试的敏感性和特异性。然而,迄今为止,尚未报道有关使用这些技术作为最常见的筛选方法之一的Gen-Probe杂交测试的辅助信息。我们检查了罗氏AMPLICOR PCR沙眼衣原体测试(Roche Diagnostic Systems,Branchburg,NJ)作为Gen-Probe PACE 2沙眼衣原体测试(加利福尼亚州圣地亚哥)的确认性测试。此外,为了减轻Gen-Probe PACE 2传输介质中干扰化合物的可能影响,我们测试了各种DNA纯化技术。研究设计:沙眼衣原体基本体用于加标PACE 2运输介质,将其连续稀释,然后通过聚合酶链反应(PCR)进行测试。进行了六个平行稀释系列:(1)通过Syva Direct Specimen Test测试的盐水稀释液,(2)通过PCR测试的Roche AMPLICOR传输介质稀释液,和(3-6)分别通过GENECLEAN II纯化的PACE 2传输介质稀释液( BIO101,Vista,CA),Puregene(Gentra Systems,Inc。,研究三角公园,北卡罗来纳州),Microcon 100(Amicon,Inc。,贝弗利,马萨诸塞州)DNA分离试剂盒,并且没有DNA纯化,全部通过PCR进行测试。然后,通过体外终点稀释试验获得最佳结果的系统用于确认先前通过Gen-Probe方法测试的人类标本。结果:PCR检测到沙眼衣原体的稀释度是PACE 2的11倍,是Syva Direct Specimen Test检测的单个基本体。通过Microcon 100试剂盒对加标的PACE 2传输介质进行的DNA纯化产生了最一致的PCR检测终点,与加标的AMPLICOR传输介质的终点相当。没有DNA纯化步骤的终点是可变的并且较低。通过PACE 2和Gen-Probe探针竞争分析阴性的78个宫颈管标本中,有12个(15.3%)通过Microcon DNA纯化/ PCR检测呈阳性。结论:PCR可以用作Gen-Probe PACE 2测试的确认方法,但是必须使用DNA纯化程序进行测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号